IP Library Granted Patent US 6,849,232
Granted Patent B2
US 6,849,232 · App. 10/094,633 · Granted Feb 1, 2005

Methods for sterilizing cross-linked gelatin compositions

Assignee: Sub-Q, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,849,232
App. No.
10/094,633
Granted
Feb 1, 2005
Kind
B2
Abstract

Disclosed are methods for sterilizing cross-linked gelatin as well as to sterilized cross-linked gelatin. In particular, the methods of this invention employ E-beam sterilization techniques.

Claims (22)

1. A method for sterilizing a cross-linked gelatin composition for use in vivo, comprising:

exposing the cross-linked gelatin composition to a sufficient dose of E-beam irradiation under conditions wherein said composition is sterilized and wherein said cross-linked gelatin composition retains a sufficient amount of fluid absorbability of about 35 grams of fluid per gram of gelatin.

2. The method of claim 1 wherein the cross-linked gelatin composition retains a sufficient amount of tensile strength.

3. A method for sterilizing a cross-linked gelatin composition for use in vivo, comprising:

exposing the cross-linked gelatin composition to a sufficient dose of E-beam irradiation under conditions wherein said composition is sterilized and wherein said cross-linked gelatin composition retains a tensile strength of about 2.5 lbs/in2.

4. The method of claim 3 wherein the cross-linked gelatin composition retains a sufficient amount of fluid absorbability.

5. A method for preparing a sterile, cross-linked gelatin composition in a packaging element, said cross-linked gelatin for use in vivo, the method comprising:

(a) selecting a packaging element;

(b) adding said cross-linked gelatin composition to the packaging element selected in (a) above; and

(c) exposing the packaging element formed in (b) above to a sufficient dosage of E-beam irradiation maintained at an initial fluence of at least 5 μCurie/cm 2 to sterilize both the packaging element and the cross-linked gelatin composition therein wherein the average bulk density of the materials comprising the packaging element is less than about 0.2 gm/cm 3 and wherein said cross-linked gelatin composition retains a sufficient amount of fluid absorbability and tensile strength.

6. A sterilized cross-linked gelatin composition characterized by a fluid absorbability of at least 30 grams of fluid per gram of gelatin and a tensile strength of greater than 2.0 lbs/in 2 .

7. The sterilized cross-linked gelatin composition of claim 6 wherein said composition has a fluid absorbability of at least 35 grams of fluid per gram of gelatin and a tensile strength of greater than 2.5 lbs/in 2 .

8. The sterilized cross-linked gelatin composition of claim 6 wherein said composition further comprises an antimicrobial agent, a growth factor, a thrombus enhancing agents or mixtures thereof.

9. The sterilized cross-linked gelatin composition of claim 8 wherein said antimicrobial agent is an antibiotic.

10. A method for preparing a sterile syringe comprising a cross-linked gelatin composition wherein said syringe is included in a packaging element which method comprises:

(a) selecting a syringe assembly comprising a holding chamber an injection port which comprising a luer hub and an ejection port which is attached to a cannula;

(b) adding to the holding chamber of said syringe a cross-linked gelatin composition in the form of a pledget;

(c) adding sterile saline to said holding chamber wherein sufficient amounts of said saline are added to hydrate said pledget;

(d) transferring the hydrated pledget into the cannula attached to the ejection port;

(e) combining at least a single syringe produced in (d) above into a packaging element;

(f) exposing the packaging element formed in (e) above to a sufficient dosage of E-beam irradiation maintained at an initial fluence of at least 5 μCurie/cm 2 to sterilize the packaging element and the syringe and the gelatin composition therein

wherein the average bulk density of the materials comprising the packaging element is less than about 0.2 gm/cm 3 and wherein said cross-linked gelatin composition retains a sufficient amount of fluid absorbability and tensile strength.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2006
From: SUB-Q, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018420/0029 →
NOTE AND WARRANT PURCHASE AGREEMENT Recorded Sep 21, 2004
From: SUB-Q, INC.
To: BOSTON SCIENTIFIC CORPORATION; PACIFIC VENTURE GROUP II, L.P.; PVG ASSOCIATES II, L.P.; PEQUOT PRIVATE EQUITY FUND II, L.P.; KINGSBURY CAPITAL PARTNERS, L.P. III; KINGSBURY CAPITAL PARTNERS, L.P. IV; HARTZLER, GEOFFREY O.; WALLACE, GEORGE; CRAGG, ANDREW H.; ALLEN FAMILY TRUST DATED 10/12/81; FEUCHTER, BRUCE
Reel/Frame 015156/0484 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEES ADDRESS (ZIP CODE) FROM 93673 TO 93673. DOCUMENT PREVIOUSLY RECORDED AT REEL 013024 FRAME 0313. Recorded Sep 12, 2003
From: ASHBY, MARK; SING, EDUARDO C.; GREFF, RICHARD J.
To: SUB-Q, INC.
Reel/Frame 013968/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2002
From: ASHBY, MARK; SING, EDUARDO C.; GREFF, RICHARD J.
To: SUB-Q, INC.
Reel/Frame 013024/0313 →
Continuity (2)
Provisional Application 6027539100 · Mar 12, 2001
Related Publication 20020190226A1 · Dec 19, 2002